Key Details
Price
$7.28Annual ROE
-63.37%Beta
1.66Events Calendar
Next earnings date:
Apr 25, 2025Recent quarterly earnings:
Feb 11, 2025Recent annual earnings:
Feb 11, 2025Next ex-dividend date:
N/ARecent ex-dividend date:
N/ANext split:
N/ARecent split:
N/AAnalyst ratings
Recent major analysts updates
Feb 12, 25 Wedbush
NeutralFeb 12, 25 Scotiabank
Sector OutperformFeb 12, 25 Needham
HoldFeb 12, 25 HC Wainwright & Co.
NeutralFeb 12, 25 Canaccord Genuity
HoldJan 2, 25 Piper Sandler
OverweightDec 16, 24 Stifel
HoldNov 21, 24 TD Cowen
HoldNov 21, 24 RBC Capital
Sector PerformNov 20, 24 Needham
HoldMarket Data
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Price
Market cap
Technical
Dividend
Sage Therapeutics doesn't have historical dividend data
Profitability
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Revenue
Profit
EPS
ROA & ROE
EBIT & EBITDA
Valuation
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
PE Ratio
PB Ratio
PS Ratio
Enterprise value
EV/EBITDA
Financial Health
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Liquidity
Leverage
Risk & Stability
Balance Sheet
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Assets
Equity
Liabilities
Debt
Expenses
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Cash Flow
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Cashflow Activities
Free CashFlow
CAPEX
Institutional Ownership
FAQ
- What is the ticker symbol for Sage Therapeutics?
- Does Sage Therapeutics pay dividends?
- What sector is Sage Therapeutics in?
- What industry is Sage Therapeutics in?
- What country is Sage Therapeutics based in?
- When did Sage Therapeutics go public?
- Is Sage Therapeutics in the S&P 500?
- Is Sage Therapeutics in the NASDAQ 100?
- Is Sage Therapeutics in the Dow Jones?
- When was Sage Therapeutics's last earnings report?
- When does Sage Therapeutics report earnings?
- Should I buy Sage Therapeutics stock now?
What is the ticker symbol for Sage Therapeutics?
The ticker symbol for Sage Therapeutics is NASDAQ:SAGE
Does Sage Therapeutics pay dividends?
No, Sage Therapeutics does not pay dividends
What sector is Sage Therapeutics in?
Sage Therapeutics is in the Healthcare sector
What industry is Sage Therapeutics in?
Sage Therapeutics is in the Biotechnology industry
What country is Sage Therapeutics based in?
Sage Therapeutics is headquartered in United States
When did Sage Therapeutics go public?
Sage Therapeutics's initial public offering (IPO) was on July 18, 2014
Is Sage Therapeutics in the S&P 500?
No, Sage Therapeutics is not included in the S&P 500 index
Is Sage Therapeutics in the NASDAQ 100?
No, Sage Therapeutics is not included in the NASDAQ 100 index
Is Sage Therapeutics in the Dow Jones?
No, Sage Therapeutics is not included in the Dow Jones index
When was Sage Therapeutics's last earnings report?
Sage Therapeutics's most recent earnings report was on Feb 11, 2025
When does Sage Therapeutics report earnings?
The next expected earnings date for Sage Therapeutics is Apr 25, 2025
Should I buy Sage Therapeutics stock now?
As of today, analysts generally recommend a 'Hold' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions